Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants
about
M2e-Based Universal Influenza A VaccinesAge-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic ImmunityIsotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunityImmunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors.Antiviral antibody responses: the two extremes of a wide spectrum.Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceIn vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance.Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells.Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunitAge-associated B cells: key mediators of both protective and autoreactive humoral responses.Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells.Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System TissueT-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus.Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatmentStudy of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial.
P2860
Q26783493-F4D0D98C-465F-426C-B943-C3C7C97E350BQ26795654-A7F4495A-47D2-4761-B7BB-FFF6EE7C152BQ33751822-CEF9BCCD-42ED-46B2-84EF-A8D404360B85Q33923199-16FEA45B-BDE6-466E-95E6-B248AFE2BB1BQ34059404-044A7073-9CB0-4E82-8C88-0B16806B45F8Q34416393-EAD5A328-9C2C-4028-B7B3-033EFE8490C5Q34430020-0D053BFA-A034-4437-9B1B-7B0A221165D5Q34457791-E311B7EE-3569-4690-B566-61614EE9EF92Q35739131-123B4DC9-DE5F-4659-9844-B720A940D06DQ36202401-6B71B6F0-B72D-4C00-BF07-D2E63730605AQ36228329-B4028051-6A45-4B3E-85BD-2258599E5637Q36228422-E31F624B-CBF0-4520-9CF1-091A065970ACQ36405084-8E71A043-14B8-4843-B2B9-D48A8C5711EAQ36488876-F1868850-26C2-47D2-B6AE-023FCD51CB3BQ36611663-5F4C9B7A-7A77-4903-AF16-33A6AB0B0E64Q36937137-15623DC0-BD90-48C4-B66D-FF5C3BAA1AD1Q37117949-85927347-4DB7-42DA-B8AC-F6D0D01E968CQ37242997-FB45EEB2-E1A5-42D3-85F4-73F84772F168Q38606892-94B29E3E-BF1D-45CC-8A61-31F8A72C82CCQ38673417-A975A7CB-984E-40EC-8303-D3531E907DF3Q38827936-3E623411-9D1E-4833-9B52-533C7E349A70Q39187784-16900A0B-35B9-4185-8910-D213D6494046Q40076766-1407E55E-4768-4CA8-B1D2-F26651F2AC1AQ40980505-CD682997-6CDF-4EB9-8A4C-B82AAAC99E19Q42276424-4012124F-3A76-47D4-969B-4E80E1764311Q42732125-BBA83439-1279-4957-94D9-E387EC57B011Q46574691-330574A6-D8C7-4AF4-99B6-CEE54AAA95FD
P2860
Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased efficacy of the immu ...... s revealed with switch mutants
@ast
Increased efficacy of the immu ...... s revealed with switch mutants
@en
Increased efficacy of the immu ...... s revealed with switch mutants
@nl
type
label
Increased efficacy of the immu ...... s revealed with switch mutants
@ast
Increased efficacy of the immu ...... s revealed with switch mutants
@en
Increased efficacy of the immu ...... s revealed with switch mutants
@nl
prefLabel
Increased efficacy of the immu ...... s revealed with switch mutants
@ast
Increased efficacy of the immu ...... s revealed with switch mutants
@en
Increased efficacy of the immu ...... s revealed with switch mutants
@nl
P2860
P1433
P1476
Increased efficacy of the immu ...... s revealed with switch mutants
@en
P2093
Dominique Markine-Goriaynoff
Jean-Paul Coutelier
P2860
P304
P356
10.1128/JVI.76.1.432-435.2002
P407
P577
2002-01-01T00:00:00Z